{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency","columns":[{"gene":"","key":"population-b39e3617f93d4f587a4d","label":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","mondoId":"MONDO:0016543","onsetQualifier":null,"originColumnKey":"MONDO:0016543/ORPHA:238583","originalViews":[{"key":"MONDO:0016543/ORPHA:238583","label":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","scopeLabel":"ORPHA:238583","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["06fb4f7b1eb86e08be0a1a734df0856df34bb675217728ab5cc34dd063a58d7d","0ff0987e61bdd7d2fdfc3acdd419c93cc1bafc5008752de4ba08dba90c7ba00a","119d86e7cfd3db19853a9b7bf9e42af87d1652f180e205cd3a1b8621c8d4d873","12ae329aa6cbdb89681fbb6fc303f6ab72c2f94296d6793c8efc0d4b334f5bfd","253e010294f63158dda465ee80c4911b67d5bdac22b8f06ff58e807dcc1dfc98","2a74fed5cadfabb07b016fad5468f8b3514534898995952859698fa4fbbdf765","308a217a601e30da4b2d7b0d8f23a8a94887e38e664e4aa9da8446bdf0f1d858","4bd1a9bf15f79fbfb7b237f8070ef3c15a844a5884ee4296f4ac0c0cad95efb4","581b28514f608ee43ebc94ba312d16e29de5f30a24a5b257fafc03ae6cc12ac1","5d27660d327f2b60b9bad1f7101026e5e9726bc90d3d2e6c292f4ff937dc5c9a","6560411796abdb6acf222f33378e86ea0f015c82598d26aea0aca9094e8ac31a","75929f589bec1954327ef9cde4a7bd9dd3d2c6032df34cd16dd1643c4e681821","77d654941758435d740f8fdc3ce4204ccca527a113d2de8f314ea3c49cb67001","9651ad3d84344e34e9a9901724bed6447fd4b27e9c8baf9da8f5f21be989c924","98c6c2b1b211a39ccee5fd63d6a6f9d0535b4c26cf08f019988e1e0fdf2ed49a","99086e94c09d41880c1766c8b2c4b1a61321aa7f1df3be24f8b29e85cd382dd3","9970b386200735aebb1275248bfccfb7069c27684edf942ce4d6c61e3b64d8b6","ab0247401915abcd38eb96784448de3f0503ec506cd361149bbff2a361b3b9fb","b3f5aa4437447ea86cb97e3beb4cb6b700e8ccf5d09d958ca0ad6dc96f92e83b","c2ba328c647e1ae1b28522b8ef25bdc162d5eb194609a6fe73767d231a260592","c5f37170549d11730101e513b7520f1058f599d69bad2aded1b8a999c7cdc8eb","d69926578899f7fa9c438bfd0e84bc28445fe2f1bd768a708e96da125251cb8c","f079bdf9247b1682ee13cd17d2ed847ff149812116e7d67580bfb84c121fde04","f9121498ce90757f5913ac392ec252288973f50e6ecd937b8e8563f35ba7c39a"],"recordQualifiers":{},"scopeLabel":"ORPHA:238583","sourceIds":["ORPHA:238583"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b39e3617f93d4f587a4d"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040210","HP:0040206","HP:0040416","HP:0000708","HP:0002135","HP:0100543","HP:6000482"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"orphanet":24}},"features":[{"hpoId":"HP:0040210","label":"Abnormal circulating biopterin concentration","primary":true},{"hpoId":"HP:0040206","label":"Abnormal circulating neopterin concentration","primary":true},{"hpoId":"HP:0040416","label":"Abnormal urinary nitrogen compound level","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0002135","label":"Basal ganglia calcification","primary":true},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":true},{"hpoId":"HP:6000482","label":"Decreased circulating catecholamine concentration","primary":true},{"hpoId":"HP:0003785","label":"Decreased CSF homovanillic acid concentration","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":false},{"hpoId":"HP:0001332","label":"Dystonia","primary":false},{"hpoId":"HP:0033594","label":"Elevated urinary 7-biopterin level","primary":false},{"hpoId":"HP:0003781","label":"Excessive salivation","primary":false},{"hpoId":"HP:0004923","label":"Hyperphenylalaninemia","primary":false},{"hpoId":"HP:0001276","label":"Hypertonia","primary":false},{"hpoId":"HP:0002917","label":"Hypomagnesemia","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0004904","label":"Maturity-onset diabetes of the young","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0012758","label":"Neurodevelopmental delay","primary":false},{"hpoId":"HP:0010553","label":"Oculogyric crisis","primary":false},{"hpoId":"HP:0001300","label":"Parkinsonism","primary":false},{"hpoId":"HP:0002421","label":"Poor head control","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0002360","label":"Sleep disturbance","primary":false}],"ledeHtml":"Tetrahydrobiopterin deficiency is a rare disorder characterized by a shortage (deficiency) of a molecule called tetrahydrobiopterin or BH4. This condition alters the levels of several substances in the body, including phenylalanine. Phenylalanine is a building block of proteins (an amino acid) that is obtained through the diet. It is found in foods that contain protein and in some artificial sweeteners. High levels of phenylalanine are present from early infancy in people with untreated tetrahydrobiopterin deficiency. This condition also alters the levels of chemicals called neurotransmitters, which transmit signals between nerve cells in the brain. Infants with tetrahydrobiopterin deficiency appear normal at birth, but medical problems ranging from mild to severe become apparent over time. Signs and symptoms of this condition can include intellectual disability, progressive problems with development, movement disorders, difficulty swallowing, seizures, behavioral problems, and an inability to control body temperature.","mondoId":"MONDO:0016543","node":{"canonicalSlug":"hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency","comparisons":[{"documentSha256":"1b2ba03faf0835d34ab5fe783adec9475ff848f02dabd1617924e0a51f4823af","key":"legacy-hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency","kind":"legacy","label":"hyperphenylalaninemia due to tetrahydrobiopterin deficiency","memberIds":["MONDO:0009862","MONDO:0009863","MONDO:0009908","MONDO:0016543","MONDO:0100186"],"mondoId":"MONDO:0016543","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency.1b2ba03faf0835d34ab5fe783adec9475ff848f02dabd1617924e0a51f4823af.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","originalSourceId":"ORPHA:238583","paragraphs":["Tetrahydrobiopterin deficiency is a rare disorder characterized by a shortage (deficiency) of a molecule called tetrahydrobiopterin or BH4. This condition alters the levels of several substances in the body, including phenylalanine. Phenylalanine is a building block of proteins (an amino acid) that is obtained through the diet. It is found in foods that contain protein and in some artificial sweeteners. High levels of phenylalanine are present from early infancy in people with untreated tetrahydrobiopterin deficiency. This condition also alters the levels of chemicals called neurotransmitters, which transmit signals between nerve cells in the brain. Infants with tetrahydrobiopterin deficiency appear normal at birth, but medical problems ranging from mild to severe become apparent over time. Signs and symptoms of this condition can include intellectual disability, progressive problems with development, movement disorders, difficulty swallowing, seizures, behavioral problems, and an inability to control body temperature."],"rawAttribution":"MONDO:0016543","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T15:51:55Z","upstream":"GARD:0007751","url":"https://rarediseases.info.nih.gov/diseases/7751"},"ownColumnKeys":["population-b39e3617f93d4f587a4d"],"publication":"published","relationships":[{"kind":"parent","label":"inborn disorder of amino acid metabolism","mondoId":"MONDO:0004736","slug":"inborn-disorder-of-amino-acid-metabolism"},{"kind":"parent","label":"autosomal recessive disease","mondoId":"MONDO:0006025","slug":null},{"kind":"child","label":"dihydropteridine reductase deficiency","mondoId":"MONDO:0009862","slug":"dihydropteridine-reductase-deficiency"},{"kind":"child","label":"BH4-deficient hyperphenylalaninemia A","mondoId":"MONDO:0009863","slug":"bh4-deficient-hyperphenylalaninemia-a"},{"kind":"child","label":"pterin-4 alpha-carbinolamine dehydratase 1 deficiency","mondoId":"MONDO:0009908","slug":"pterin-4-alpha-carbinolamine-dehydratase-1-deficiency"},{"kind":"child","label":"GTP cyclohydrolase I deficiency with hyperphenylalaninemia","mondoId":"MONDO:0100186","slug":"gtp-cyclohydrolase-i-deficiency-with-hyperphenylalaninemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"06fb4f7b1eb86e08be0a1a734df0856df34bb675217728ab5cc34dd063a58d7d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012758","is_excluded":false,"label":"Neurodevelopmental delay","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ff0987e61bdd7d2fdfc3acdd419c93cc1bafc5008752de4ba08dba90c7ba00a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010553","is_excluded":false,"label":"Oculogyric crisis","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"119d86e7cfd3db19853a9b7bf9e42af87d1652f180e205cd3a1b8621c8d4d873","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040416","is_excluded":false,"label":"Abnormal urinary nitrogen compound level","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"12ae329aa6cbdb89681fbb6fc303f6ab72c2f94296d6793c8efc0d4b334f5bfd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"253e010294f63158dda465ee80c4911b67d5bdac22b8f06ff58e807dcc1dfc98","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003781","is_excluded":false,"label":"Excessive salivation","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2a74fed5cadfabb07b016fad5468f8b3514534898995952859698fa4fbbdf765","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"308a217a601e30da4b2d7b0d8f23a8a94887e38e664e4aa9da8446bdf0f1d858","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004923","is_excluded":false,"label":"Hyperphenylalaninemia","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4bd1a9bf15f79fbfb7b237f8070ef3c15a844a5884ee4296f4ac0c0cad95efb4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002360","is_excluded":false,"label":"Sleep disturbance","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"581b28514f608ee43ebc94ba312d16e29de5f30a24a5b257fafc03ae6cc12ac1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003785","is_excluded":false,"label":"Decreased CSF homovanillic acid concentration","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5d27660d327f2b60b9bad1f7101026e5e9726bc90d3d2e6c292f4ff937dc5c9a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002421","is_excluded":false,"label":"Poor head control","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6560411796abdb6acf222f33378e86ea0f015c82598d26aea0aca9094e8ac31a","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:6000482","is_excluded":false,"label":"Decreased circulating catecholamine concentration","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"75929f589bec1954327ef9cde4a7bd9dd3d2c6032df34cd16dd1643c4e681821","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"77d654941758435d740f8fdc3ce4204ccca527a113d2de8f314ea3c49cb67001","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004904","is_excluded":false,"label":"Maturity-onset diabetes of the young","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9651ad3d84344e34e9a9901724bed6447fd4b27e9c8baf9da8f5f21be989c924","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040206","is_excluded":false,"label":"Abnormal circulating neopterin concentration","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98c6c2b1b211a39ccee5fd63d6a6f9d0535b4c26cf08f019988e1e0fdf2ed49a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0033594","is_excluded":false,"label":"Elevated urinary 7-biopterin level","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"99086e94c09d41880c1766c8b2c4b1a61321aa7f1df3be24f8b29e85cd382dd3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040210","is_excluded":false,"label":"Abnormal circulating biopterin concentration","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9970b386200735aebb1275248bfccfb7069c27684edf942ce4d6c61e3b64d8b6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002135","is_excluded":false,"label":"Basal ganglia calcification","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ab0247401915abcd38eb96784448de3f0503ec506cd361149bbff2a361b3b9fb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001300","is_excluded":false,"label":"Parkinsonism","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3f5aa4437447ea86cb97e3beb4cb6b700e8ccf5d09d958ca0ad6dc96f92e83b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c2ba328c647e1ae1b28522b8ef25bdc162d5eb194609a6fe73767d231a260592","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001276","is_excluded":false,"label":"Hypertonia","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c5f37170549d11730101e513b7520f1058f599d69bad2aded1b8a999c7cdc8eb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d69926578899f7fa9c438bfd0e84bc28445fe2f1bd768a708e96da125251cb8c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f079bdf9247b1682ee13cd17d2ed847ff149812116e7d67580bfb84c121fde04","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002917","is_excluded":false,"label":"Hypomagnesemia","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f9121498ce90757f5913ac392ec252288973f50e6ecd937b8e8563f35ba7c39a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:238583","disease_name":"Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:238583","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/7751\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016543\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0007751</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Tetrahydrobiopterin deficiency is a rare disorder characterized by a shortage (deficiency) of a molecule called tetrahydrobiopterin or BH4. This condition alters the levels of several substances in the body, including phenylalanine. Phenylalanine is a building block of proteins (an amino acid) that is obtained through the diet. It is found in foods that contain protein and in some artificial sweeteners. High levels of phenylalanine are present from early infancy in people with untreated tetrahydrobiopterin deficiency. This condition also alters the levels of chemicals called neurotransmitters, which transmit signals between nerve cells in the brain. Infants with tetrahydrobiopterin deficiency appear normal at birth, but medical problems ranging from mild to severe become apparent over time. Signs and symptoms of this condition can include intellectual disability, progressive problems with development, movement disorders, difficulty swallowing, seizures, behavioral problems, and an inability to control body temperature.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/7751\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hyperphenylalaninemia-due-to-tetrahydrobiopterin-deficiency","sourceDocuments":[{"name":"GARD: Hyperphenylalaninemia due to tetrahydrobiopterin deficiency","reviewed":null,"source_release":"2026-10-21T15:51:55Z","url":"https://rarediseases.info.nih.gov/diseases/7751"},{"name":"MONDO: hyperphenylalaninemia due to tetrahydrobiopterin deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016543"}],"sourceNote":"","synonyms":["hyperphenylalaninemia due to BH4 deficiency","hyperphenylalaninemia due to tetrahydrobiopterin deficiency","non-phenylketonuric hyperphenylalaninemia"],"takeawayHtml":"","title":"hyperphenylalaninemia due to tetrahydrobiopterin deficiency"},"schemaVersion":1}
